| Cumberland Hall Hospital | |
|
270 Walton Way Hopkinsville KY 42240 | |
| (270) 886-1919 | |
| (270) 886-1335 |
| Full Name | Cumberland Hall Hospital |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 270 Walton Way, Hopkinsville, Kentucky |
| Authorized Official Name and Position | Steve Filton (CFO/SVP) |
| Authorized Official Contact | 6107683300 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Cumberland Hall Hospital 270 Walton Way Hopkinsville KY 42240 Ph: (270) 886-1919 | Cumberland Hall Hospital 270 Walton Way Hopkinsville KY 42240 Ph: (270) 886-1919 |
| NPI Number | 1720353501 |
|---|---|
| Provider Enumeration Date | 03/13/2012 |
| Last Update Date | 06/16/2020 |
| Certification Date | 06/16/2020 |
| Medicare PECOS PAC ID | 6608833520 |
|---|---|
| Medicare Enrollment ID | O20041213000659 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720353501 | NPI | - | NPPES |
| Provider Name | Max C Kinnaman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1376693176 PECOS PAC ID: 7517909500 Enrollment ID: I20050601000034 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Michael John Light |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1508863648 PECOS PAC ID: 7214031699 Enrollment ID: I20070709000425 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Anitha Mandadapu |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699816744 PECOS PAC ID: 0840348124 Enrollment ID: I20090424000021 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | James J Staudenmeier |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1174514657 PECOS PAC ID: 6204070402 Enrollment ID: I20150316000626 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Kathryn Nesbitt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346623303 PECOS PAC ID: 8325352180 Enrollment ID: I20150806012376 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Hope R Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922482587 PECOS PAC ID: 7315234382 Enrollment ID: I20161011001601 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Oleksandr Osipchuk |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1700045416 PECOS PAC ID: 3476604406 Enrollment ID: I20171020002509 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Janice Bunch |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1861527624 PECOS PAC ID: 6709211642 Enrollment ID: I20200122002681 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Victor Arballo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023462447 PECOS PAC ID: 8729377429 Enrollment ID: I20200717002251 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Walter E Wilson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1821485400 PECOS PAC ID: 1254643240 Enrollment ID: I20200805002592 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Kimberly Buckner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437825767 PECOS PAC ID: 4486043924 Enrollment ID: I20211122002788 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Hannah E Hodge |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679145999 PECOS PAC ID: 8527458025 Enrollment ID: I20211123002385 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Brian Hunter Levins |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053675090 PECOS PAC ID: 8426309287 Enrollment ID: I20220630000003 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Melissa Cheatham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154034221 PECOS PAC ID: 5496118614 Enrollment ID: I20230905003486 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Brian Hunter Levins |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053675090 PECOS PAC ID: 8426309287 Enrollment ID: I20230919000343 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Rachel Helen Alison |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1265095087 PECOS PAC ID: 8123431442 Enrollment ID: I20231108003385 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
| Provider Name | Melanie S Haddox |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1609840099 PECOS PAC ID: 6406899822 Enrollment ID: I20240105001328 |
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
News Archive
The demand for transparency through publicly available healthcare data is on the rise. This is the case for administrative and clinical data for research, and for clinical trials data used to support new drug approvals. Broad data access has a measurable impact on research and policy making.
Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.
Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).
› Verified 9 days ago
Mindcare Mental Health Group Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3091 Singletree Dr, Hopkinsville, KY 42240 Phone: 270-498-6465 | |
Western State Nursing Facility Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2400 Russellville Rd, Us 68 East, Hopkinsville, KY 42241 Phone: 502-886-4431 Fax: 270-886-4487 | |
One4all Counseling Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 105 S Main St # 550, Hopkinsville, KY 42240 Phone: 270-449-1631 | |
Women's Wellness Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1918 Bentley St, Hopkinsville, KY 42240 Phone: 270-348-6167 | |
Gazza Lab Neurology, Psc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1830 High St, Suite A, Hopkinsville, KY 42240 Phone: 270-886-2559 Fax: 270-886-0388 | |
Jennie Stuart Medical Center Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 320 W 18th St, Hopkinsville, KY 42240 Phone: 270-887-0100 Fax: 270-887-9266 | |
Solutions Counseling Center Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1100 S Main St, Suite 33, Hopkinsville, KY 42240 Phone: 270-962-7350 Fax: 270-874-2322 |